Cite
He BL, Yang N, Man CH, et al. Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia. EMBO Mol Med. 2020;12(8):e12911doi: 10.15252/emmm.202012911.
He, B. L., Yang, N., Man, C. H., Ng, N. K., Cher, C. Y., Leung, H. C., Kan, L. L., Cheng, B. Y., Lam, S. S., Wang, M. L., Zhang, C. X., Kwok, H., Cheng, G., Sharma, R., Ma, A. C., So, C. W. E., Kwong, Y. L., & Leung, A. Y. (2020). Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia. EMBO molecular medicine, 12(8), e12911. https://doi.org/10.15252/emmm.202012911
He, Bai-Liang, et al. "Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia." EMBO molecular medicine vol. 12,8 (2020): e12911. doi: https://doi.org/10.15252/emmm.202012911
He BL, Yang N, Man CH, Ng NK, Cher CY, Leung HC, Kan LL, Cheng BY, Lam SS, Wang ML, Zhang CX, Kwok H, Cheng G, Sharma R, Ma AC, So CWE, Kwong YL, Leung AY. Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia. EMBO Mol Med. 2020 Aug 07;12(8):e12911. doi: 10.15252/emmm.202012911. PMID: 32767634; PMCID: PMC7411562.
Copy
Download .nbib